Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.88 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.85 |
| ▸ | CNR1 | P21554 | 5/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | HPGD | P15428 | 2/20 | 0.74 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.74 |
| ▸ | BLM | P54132 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2088277 | 1.00 | EPHX2 (0.88) | EPHX2SLC6A5CNR1KDM4ELPAR1 | |
| SCHEMBL395220 | 1.00 | EPHX2 (0.88) | EPHX2SLC6A5CNR1KDM4ELPAR1 | |
| SCHEMBL4827900 | 1.00 | EPHX2 (0.88) | EPHX2SLC6A5CNR1KDM4ELPAR1 | |
| SCHEMBL422661 | 1.00 | EPHX2 (0.88) | EPHX2SLC6A5CNR1KDM4ELPAR1 | |
| SCHEMBL25334864 | 1.00 | EPHX2 (0.88) | EPHX2SLC6A5CNR1KDM4ELPAR1 | |
| SCHEMBL4827898 | 1.00 | EPHX2 (0.88) | EPHX2SLC6A5CNR1KDM4ELPAR1 | |
| SCHEMBL24233390 | 1.00 | EPHX2 (0.88) | EPHX2SLC6A5CNR1KDM4ELPAR1 | |
| SCHEMBL9517258 | 1.00 | EPHX2 (0.88) | EPHX2SLC6A5CNR1KDM4ELPAR1 | |
| SCHEMBL20987095 | 1.00 | EPHX2 (0.88) | EPHX2SLC6A5CNR1KDM4ELPAR1 | |
| SCHEMBL421889 | 1.00 | EPHX2 (0.88) | EPHX2SLC6A5CNR1KDM4ELPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570879-B2 | Removable adhesive composition and a label containing it | UPM RAFLATAC OY (FI) | 2026-03-10 | — | — | US | disclosed |
| EP-4368681-A1 | A RELEASE LINER AND A LABEL LAMINATE | UPM Raflatac Oy (FI) | 2024-05-15 | — | — | EP | disclosed |
| US-20240150625-A1 | RELEASE LINER AND A LABEL LAMINATE | UPM RAFLATAC OY (FI) | 2024-05-09 | — | — | US | disclosed |
| US-20220228043-A1 | REMOVABLE ADHESIVE COMPOSITION AND A LABEL CONTAINING IT | UPM RAFLATAC OY (FI) | 2022-07-21 | — | — | US | disclosed |
| WO-2020240075-A1 | REMOVABLE ADHESIVE COMPOSITION AND A LABEL CONTAINING IT | UPM RAFLATAC OY (FI) | 2020-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570879-B2 | Removable adhesive composition and a label containing it | ITGA1, ITGA2, ITGA2B | EPHX2 268/4885SLC6A5 2216/4885CNR1 4440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.